{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:00Z","timestamp":1740147240745,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04791-x","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:01:53Z","timestamp":1728864113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rituximab induced cerebral venous sinus thrombosis in a patient with anti-N-methyl-d-aspartate receptor-antibody encephalitis: a case report and review of literature"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3828-6863","authenticated-orcid":false,"given":"S.","family":"Maathury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Thevarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"3","key":"4791_CR1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J, Bousser MG, Barinagarrementeria F, Investigators ISCVT. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35(3):664\u201370. https:\/\/doi.org\/10.1161\/01.STR.0000117571.76197.26.","journal-title":"Stroke"},{"key":"4791_CR2","doi-asserted-by":"publisher","first-page":"671101","DOI":"10.3389\/fimmu.2021.671101","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Lang Y, Zhang W, Cui L, Deng F. Characteristics and management of autoimmune disease-associated cerebral venous sinus thrombosis. Front Immunol. 2021;12:671101. https:\/\/doi.org\/10.3389\/fimmu.2021.671101.","journal-title":"Front Immunol"},{"issue":"9","key":"4791_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351. https:\/\/doi.org\/10.1056\/NEJMra1708712.","journal-title":"N Engl J Med"},{"issue":"5","key":"4791_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/RHU.0000000000000577","volume":"23","author":"YW Hsu","year":"2017","unstructured":"Hsu YW, Juan CJ, Lee JT, Lin YK, Lai CH, Yang FC. Anti-N-Methyl-D-aspartate-receptor encephalitis complicated with antiphospholipid syndrome and cerebral venous thrombosis. J Clin Rheumatol Pract Reports Rheumat Musculoskeletal Dis. 2017;23(5):294\u20135. https:\/\/doi.org\/10.1097\/RHU.0000000000000577.","journal-title":"J Clin Rheumatol Pract Reports Rheumat Musculoskeletal Dis"},{"key":"4791_CR5","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16l01978.10.4088\/PCC.16l01978","author":"G Singh","year":"2016","unstructured":"Singh G, Prabhakar D. Neuropsychiatric presentation of anti-N-Methyl-D-aspartate receptor encephalitis with comorbid sinus venous thrombosis. Primary Care Compan CNS Disord. 2016. https:\/\/doi.org\/10.4088\/PCC.16l01978.10.4088\/PCC.16l01978.","journal-title":"Primary Care Compan CNS Disord"},{"key":"4791_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2021.09.002","author":"NU Khan","year":"2021","unstructured":"Khan NU, Hassan M, Jan Z, et al. A rare case of anti-NMDA receptor encephalitis with CVST. Brain Haemorrages. 2021. https:\/\/doi.org\/10.1016\/j.hest.2021.09.002.","journal-title":"Brain Haemorrages"},{"issue":"4","key":"4791_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","volume":"155","author":"I Marie","year":"2006","unstructured":"Marie I, Maurey G, Herv\u00e9 F, Hellot MF, Levesque H. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol. 2006;155(4):714\u201321. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07390.x.","journal-title":"Br J Dermatol"},{"key":"4791_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1752-1947-8-100","volume":"8","author":"T Chang","year":"2014","unstructured":"Chang T, de Alwis JS, Samarasekara N, Rajapakse S. Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report. J Med Case Rep. 2014;8:100. https:\/\/doi.org\/10.1186\/1752-1947-8-100.","journal-title":"J Med Case Rep"},{"issue":"5","key":"4791_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1378\/chest.12-1446","volume":"143","author":"D Stuijver","year":"2013","unstructured":"Stuijver D, Majoor CJ, van Zaane B, Souverein PC, de Boer A, Dekkers OM, B\u00fcller HR, Gerdes V. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest. 2013;143(5):1337\u201342. https:\/\/doi.org\/10.1378\/chest.12-1446.","journal-title":"Chest"},{"issue":"4","key":"4791_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/jth.13265","volume":"14","author":"CJ Majoor","year":"2016","unstructured":"Majoor CJ, Sneeboer MM, de Kievit A, Meijers JC, van der Poll T, Lutter R, Bel EH, Kamphuisen PW. The influence of corticosteroids on hemostasis in healthy subjects. J Thrombosis Haemostasis JTH. 2016;14(4):716\u201323. https:\/\/doi.org\/10.1111\/jth.13265.","journal-title":"J Thrombosis Haemostasis JTH"},{"issue":"9","key":"4791_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s002770000163","volume":"79","author":"M Feuring-Buske","year":"2000","unstructured":"Feuring-Buske M, Kneba M, Unterhalt M, Engert A, Gramatzki M, Hiller E, Tr\u00fcmper L, Brugger W, Ostermann H, Atzpodien J, Hallek M, Aulitzky E, Hiddemann W. IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group. Ann Hematol. 2000;79(9):493\u2013500. https:\/\/doi.org\/10.1007\/s002770000163.","journal-title":"Ann Hematol"},{"issue":"2","key":"4791_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","volume":"156","author":"E Schmidt","year":"2007","unstructured":"Schmidt E, Seitz CS, Benoit S, Br\u00f6cker EB, Goebeler M. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol. 2007;156(2):352\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07646.x.","journal-title":"Br J Dermatol"},{"key":"4791_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000357031","volume":"158","author":"I Shimanovich","year":"2008","unstructured":"Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol. 2008;158:382\u20138. https:\/\/doi.org\/10.1159\/000357031.","journal-title":"Br J Dermatol"},{"issue":"7","key":"4791_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-4632.2012.5847.x","volume":"52","author":"K Balighi","year":"2013","unstructured":"Balighi K, Daneshpazhooh M, Khezri S, Mahdavi-nia M, Hajiseyed-javadi M, Chams-Davatchi C. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial. Int J Dermatol. 2013;52(7):862\u20137. https:\/\/doi.org\/10.1111\/j.1365-4632.2012.5847.x.","journal-title":"Int J Dermatol"},{"issue":"4","key":"4791_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/0378-6323.136832","volume":"80","author":"PJ Londhe","year":"2014","unstructured":"Londhe PJ, Kalyanpad Y, Khopkar US. Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus. Indian J Dermatol Venereol Leprol. 2014;80(4):300\u20135. https:\/\/doi.org\/10.4103\/0378-6323.136832.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4791_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/ds.ds_7_21","volume":"39","author":"KJ Wu","year":"2021","unstructured":"Wu KJ, Wei KC. Venous thromboembolism in a case with pemphigus vulgaris after infusion of rituximab plus systemic glucocorticoids and azathioprine: a possible adverse effect of rituximab? Dermatol Sin. 2021;39:103\u20134. https:\/\/doi.org\/10.4103\/ds.ds_7_21.","journal-title":"Dermatol Sin"},{"key":"4791_CR17","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1182\/blood-2019-126974","volume":"134","author":"L Garabet","year":"2019","unstructured":"Garabet L, Holme PA, Darne B, et al. The risk of thromboembolism associated with treatment of ITP with rituximab: adverse event reported in two randomized controlled trials. Blood. 2019;134:4892. https:\/\/doi.org\/10.1182\/blood-2019-126974.","journal-title":"Blood"},{"issue":"2","key":"4791_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/rheumatology\/ken421","volume":"48","author":"K Suzuki","year":"2009","unstructured":"Suzuki K, Nagasawa H, Kameda H, Amano K, Kondo T, Itoyama S, Tanaka Y, Takeuchi T. Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I\/II clinical trial for refractory systemic lupus erythematosus. Rheumatology (Oxford). 2009;48(2):198\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/ken421.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4791_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1078155214543278","volume":"22","author":"R Dada","year":"2016","unstructured":"Dada R, Zekri J, Ramal B, Ahmad K. Acute jugular vein thrombosis during rituximab administration: review of the literature. J Oncol Pharmacy Pract Off Publ Int Soc Oncol Pharmacy Pract. 2016;22(1):165\u20139. https:\/\/doi.org\/10.1177\/1078155214543278.","journal-title":"J Oncol Pharmacy Pract Off Publ Int Soc Oncol Pharmacy Pract"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04791-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04791-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04791-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:02:56Z","timestamp":1728864176000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04791-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4791"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04791-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}